Ticker League

Cash on Hand for Abbott Laboratories (ABT)

As of · Reported

Metric

Latest period

$7.29B

YoY change

+12.2%

5Y CAGR

+4.6%

Peak year (2016)

$18.77B

Cash on Hand history chart for Abbott Laboratories (ABT) from 1985 to 2025

Latest: $8.94B

Cash on Hand growth chart for Abbott Laboratories (ABT) from 1985 to 2025

Latest: +12.2%

Cash on Hand history table for Abbott Laboratories (ABT) from 1985 to 2025

  • 2025$8.94B+12.2%
  • 2024$7.97B+9.5%
  • 2023$7.28B-28.4%
  • 2022$10.17B-0.8%
  • 2021$10.25B+43.4%
  • 2020$7.15B+72.7%
  • 2019$4.14B+1.3%
  • 2018$4.09B-57.5%
  • 2017$9.61B-48.8%
  • 2016$18.77B+206.5%
  • 2015$6.13B+37.3%
  • 2014$4.46B-44.9%
  • 2013$8.10B-46.6%
  • 2012$15.17B+87.4%
  • 2011$8.10B+10.6%
  • 2010$7.32B-26.3%
  • 2009$9.93B+95.5%
  • 2008$5.08B+80.1%
  • 2007$2.82B+105.4%
  • 2006$1.37B-53.5%
  • 2005$2.96B+43.6%
  • 2004$2.06B+60.1%
  • 2003$1.29B+33.2%
  • 2002$966.13M+35.4%
  • 2001$713.54M-38.3%
  • 2000$1.16B+59.9%
  • 1999$723.30M+88.7%
  • 1998$383.32M+48.0%
  • 1997$259.01M+110.4%
  • 1996$123.08M-61.0%
  • 1995$315.70M+0.1%
  • 1994$315.33M-16.8%
  • 1993$378.82M+224.9%
  • 1992$116.60M+93.0%
  • 1991$60.40M+77.6%
  • 1990$34.00M+150.0%
  • 1989$13.60M-97.7%
  • 1988$582.60M+12.1%
  • 1987$519.90M+8.0%
  • 1986$481.60M+10.1%
  • 1985$437.50M—

Cash on Hand values are taken from Abbott Laboratories's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Cash on Hand at Abbott Laboratories (ABT)

According to Abbott Laboratories's latest reported financial statements, the company's latest reported cash and short-term investments is $7.29B. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Abbott Laboratories (ABT) cash and short-term investments is $8.94B – grew 12.2% year-over-year.

Through 2020–2025 (5 years), Abbott Laboratories cash and short-term investments delivered a +4.6% annualised rate; sustaining 2 straight years of year-over-year growth.

Between 2016 and 2025, Abbott Laboratories cash and short-term investments plunged 52.4%, falling from $18.77B to $8.94B.

$18.77B stands as the all-time-high annual cash and short-term investments, posted in 2016, against a low of $13.60M during 1989.

Abbott Laboratories Cash on Hand by Year

Abbott Laboratories Cash on Hand 2025: $8.94B

2025's cash and short-term investments for Abbott Laboratories came in at $8.94B, grew 12.2% from 2024.

Abbott Laboratories Cash on Hand 2024: $7.97B

Abbott Laboratories posted cash and short-term investments of $7.97B in 2024, grew 9.5% from 2023.

Abbott Laboratories Cash on Hand 2023: $7.28B

In 2023, Abbott Laboratories reported cash and short-term investments of $7.28B, declined 28.4% below 2022.

Abbott Laboratories Cash on Hand 2022: $10.17B

Abbott Laboratories cash and short-term investments in 2022 was $10.17B, edged down 0.8% below 2021.

Abbott Laboratories Cash on Hand 2021: $10.25B

Abbott Laboratories cash and short-term investments in 2021 was $10.25B.

See more financial history for Abbott Laboratories (ABT).

Sector peers by Cash on Hand

Healthcare peers of Abbott Laboratories (ABT), ranked by their latest cash and short-term investments

Frequently asked questions

Abbott Laboratories (ABT) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview